Effects of prescription niacin and omega-3 fatty acids on lipids and vascular function in metabolic syndrome: a randomized controlled trial

The metabolic syndrome includes both dyslipidemia and impaired vascular function. Because extended-release niacin (ERN) and prescription omega-3 acid ethyl-esters (P-OM3) independently improve these characteristics, we tested their effects in combination. Sixty metabolic syndrome subjects were rando...

Descripción completa

Detalles Bibliográficos
Autores principales: Shearer, Gregory C., Pottala, James V., Hansen, Susan N., Brandenburg, Verdayne, Harris, William S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society for Biochemistry and Molecular Biology 2012
Materias:
Patient-Oriented and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3466011/
https://www.ncbi.nlm.nih.gov/pubmed/22892157
http://dx.doi.org/10.1194/jlr.P022392

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3466011/
https://www.ncbi.nlm.nih.gov/pubmed/22892157
http://dx.doi.org/10.1194/jlr.P022392

Ejemplares similares